Bio-Rad Labs (BIO) Misses Q3 EPS by 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Bio-Rad Labs (BIO) Misses Q3 EPS by 24c
November 1, 2018 4:30 PM EDT
HERCULES, Calif.--(BUSINESS WIRE)--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life
science research and clinical diagnostic products, today announced
financial results for the third quarter ended September 30, 2018.
Third-quarter 2018 net sales were $545.1 million, an increase of 2.1
percent compared to $534.1 million reported for the third quarter of
2017. On a currency-neutral basis, quarterly sales increased 3.4 percent
compared to the same period in 2017, reflecting growth across the
business. Third-quarter gross margin was 52.6 percent compared to 56.0
percent during the third quarter in 2017. Gross margin in the third
quarter of 2018 was impacted by higher costs for service, warranty... More
